These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 19752423)

  • 1. Description of the Age-Related Eye Disease Study 9-step severity scale applied to participants in the Complications of Age-related Macular Degeneration Prevention Trial.
    Ying GS; Maguire MG; Alexander J; Martin RW; Antoszyk AN;
    Arch Ophthalmol; 2009 Sep; 127(9):1147-51. PubMed ID: 19752423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for choroidal neovascularization and geographic atrophy in the complications of age-related macular degeneration prevention trial.
    Complications of Age-related Macular Degeneration Prevention Trial (CAPT) Research Group
    Ophthalmology; 2008 Sep; 115(9):1474-9, 1479.e1-6. PubMed ID: 18502512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Age-Related Eye Disease Study severity scale for age-related macular degeneration: AREDS Report No. 17.
    Davis MD; Gangnon RE; Lee LY; Hubbard LD; Klein BE; Klein R; Ferris FL; Bressler SB; Milton RC;
    Arch Ophthalmol; 2005 Nov; 123(11):1484-98. PubMed ID: 16286610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validating the AREDS Simplified Severity Scale of Age-Related Macular Degeneration with 5- and 10-Year Incident Data in a Population-Based Sample.
    Liew G; Joachim N; Mitchell P; Burlutsky G; Wang JJ
    Ophthalmology; 2016 Sep; 123(9):1874-8. PubMed ID: 27378016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of choroidal neovascularization in the complications of age-related macular degeneration prevention trial.
    Maguire MG; Alexander J; Fine SL;
    Ophthalmology; 2008 Sep; 115(9):1468-73, 1473.e1-2. PubMed ID: 18486222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ten-year follow-up of age-related macular degeneration in the age-related eye disease study: AREDS report no. 36.
    Chew EY; Clemons TE; Agrón E; Sperduto RD; Sangiovanni JP; Davis MD; Ferris FL;
    JAMA Ophthalmol; 2014 Mar; 132(3):272-7. PubMed ID: 24385141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Population-Based Ultra-Widefield Digital Image Grading Study for Age-Related Macular Degeneration-Like Lesions at the Peripheral Retina.
    Lengyel I; Csutak A; Florea D; Leung I; Bird AC; Jonasson F; Peto T
    Ophthalmology; 2015 Jul; 122(7):1340-7. PubMed ID: 25870081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age-related macular degeneration and risk factors for the development of choroidal neovascularisation in the fellow eye: a 3-year follow-up study.
    Silva R; Cachulo ML; Fonseca P; Bernardes R; Nunes S; Vilhena N; Faria de Abreu JR
    Ophthalmologica; 2011; 226(3):110-8. PubMed ID: 21822000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drusen Volume and Retinal Pigment Epithelium Abnormal Thinning Volume Predict 2-Year Progression of Age-Related Macular Degeneration.
    Folgar FA; Yuan EL; Sevilla MB; Chiu SJ; Farsiu S; Chew EY; Toth CA;
    Ophthalmology; 2016 Jan; 123(1):39-50.e1. PubMed ID: 26578448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A simplified severity scale for age-related macular degeneration: AREDS Report No. 18.
    Ferris FL; Davis MD; Clemons TE; Lee LY; Chew EY; Lindblad AS; Milton RC; Bressler SB; Klein R;
    Arch Ophthalmol; 2005 Nov; 123(11):1570-4. PubMed ID: 16286620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prophylactic treatment of age-related macular degeneration report number 1: 810-nanometer laser to eyes with drusen. Unilaterally eligible patients.
    Friberg TR; Musch DC; Lim JI; Morse L; Freeman W; Sinclair S;
    Ophthalmology; 2006 Apr; 113(4):622.e1. PubMed ID: 16581422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for the incidence of Advanced Age-Related Macular Degeneration in the Age-Related Eye Disease Study (AREDS) AREDS report no. 19.
    Clemons TE; Milton RC; Klein R; Seddon JM; Ferris FL;
    Ophthalmology; 2005 Apr; 112(4):533-9. PubMed ID: 15808240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statin use and the incidence of advanced age-related macular degeneration in the Complications of Age-related Macular Degeneration Prevention Trial.
    Maguire MG; Ying GS; McCannel CA; Liu C; Dai Y;
    Ophthalmology; 2009 Dec; 116(12):2381-5. PubMed ID: 19850347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fifteen-year cumulative incidence of age-related macular degeneration: the Beaver Dam Eye Study.
    Klein R; Klein BE; Knudtson MD; Meuer SM; Swift M; Gangnon RE
    Ophthalmology; 2007 Feb; 114(2):253-62. PubMed ID: 17270675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of Deep Learning for Detailed Severity Characterization and Estimation of 5-Year Risk Among Patients With Age-Related Macular Degeneration.
    Burlina PM; Joshi N; Pacheco KD; Freund DE; Kong J; Bressler NM
    JAMA Ophthalmol; 2018 Dec; 136(12):1359-1366. PubMed ID: 30242349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for second eye progression to advanced age-related macular degeneration: SST report No. 21 Submacular Surgery Trials Research Group.
    ; Solomon SD; Jefferys JL; Hawkins BS; Bressler NM; Bressler SB
    Retina; 2009 Sep; 29(8):1080-90. PubMed ID: 19734762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural history of drusenoid pigment epithelial detachment in age-related macular degeneration: Age-Related Eye Disease Study Report No. 28.
    Cukras C; Agrón E; Klein ML; Ferris FL; Chew EY; Gensler G; Wong WT;
    Ophthalmology; 2010 Mar; 117(3):489-99. PubMed ID: 20079925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autofluorescence characteristics of early, atrophic, and high-risk fellow eyes in age-related macular degeneration.
    Smith RT; Chan JK; Busuoic M; Sivagnanavel V; Bird AC; Chong NV
    Invest Ophthalmol Vis Sci; 2006 Dec; 47(12):5495-504. PubMed ID: 17122141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic benefits of infrared (810-nm) diode laser macular grid photocoagulation in prophylactic treatment of nonexudative age-related macular degeneration: two-year results of a randomized pilot study.
    Olk RJ; Friberg TR; Stickney KL; Akduman L; Wong KL; Chen MC; Levy MH; Garcia CA; Morse LS
    Ophthalmology; 1999 Nov; 106(11):2082-90. PubMed ID: 10571341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laser treatment in patients with bilateral large drusen: the complications of age-related macular degeneration prevention trial.
    Complications of Age-Related Macular Degeneration Prevention Trial Research Group
    Ophthalmology; 2006 Nov; 113(11):1974-86. PubMed ID: 17074563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.